Template:Cervicitis Urethritis Antibiotics: Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:
**[[Azithromycin]] 1g PO once OR
**[[Azithromycin]] 1g PO once OR
**[[Doxycycline]] 100mg PO BID x 7 days
**[[Doxycycline]] 100mg PO BID x 7 days
====Cephalosporin Allergy====
*[[Azithromycin]] 2g PO once PLUS
**[[Gentamicin]] 240mg IM once<ref>[http://www.cdc.gov/std/tg2015/ CDC: 2015 Sexually Transmitted Diseases Treatment Guidelines]</ref>
**In theory this high dose macrolide will provide treatment for both [[GC]] and [[Chlamydia]]


====Partner treatment====
====Partner treatment====
Line 9: Line 14:
**[[Azithromycin]] 1g PO once OR
**[[Azithromycin]] 1g PO once OR
**[[Doxycycline]] 100mg PO BID x 7 days
**[[Doxycycline]] 100mg PO BID x 7 days
====Cephalosporin Allergy====
*[[Azithromycin]] 2g PO once PLUS
**[[Gentamicin]] 240mg IM once<ref>[http://www.cdc.gov/std/tg2015/ CDC: 2015 Sexually Transmitted Diseases Treatment Guidelines]</ref>
**In theory this high dose macrolide will provide treatment for both [[GC]] and [[Chlamydia]]


====Associated [[Bacterial Vaginosis]] or [[Trichomonas vaginalis]]====
====Associated [[Bacterial Vaginosis]] or [[Trichomonas vaginalis]]====
{{Trichomonas antibiotics}}
{{Trichomonas antibiotics}}

Revision as of 12:21, 31 October 2017

treatment cover gonorrhea and chlamydia jointly

Uncomplicated Infection

Cephalosporin Allergy

Partner treatment

Associated Bacterial Vaginosis or Trichomonas vaginalis

Non-Pregnant

Pregnant

Only treat if the patient is symptomatic

Sexual Partner Treatment

  1. CDC: 2015 Sexually Transmitted Diseases Treatment Guidelines
  2. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon
  3. CDC Trichomoniasis 2021. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm
  4. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon